Interaction between aspirin and ACE inhibitors: Resolving discrepancies using a meta-analysis

Drug Safety

Volumn 25, Issue 5, 2002, Pages 373-378

  Takkouche, Bahi ^a,d   Etminan, Mahyar ^b   Caamaño, Francisco ^a   Rochon, Paula A ^b,c  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSITY OF TORONTO   (Canada)

^c Kunin Lunenfeld Applied Research Unit and Department of Food and Nutrition Services and Baycrest Centre for Geriatric Care   (Canada)

^d UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LISINOPRIL; TRANDOLAPRIL; ZOFENOPRIL;

ARTICLE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DATA ANALYSIS; DATA BASE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; HEART LEFT VENTRICLE FAILURE; HUMAN; META ANALYSIS; MORTALITY; PRIORITY JOURNAL;

EID: 0036283175     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200225050-00005     Document Type: Article

References (26)

1. The effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure
2. Effects of angiotensin converting inhibitor, ramipril, on cardiovascular events in high risk patients
3. 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: Executive summary and recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
4. Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease
5. Antiplatelet agents and survival: A cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial
6. Aspirin and angiotensin-converting enzyme inhibitors among elderly survivors of hospitalization for an acute myocardial infarction
7. How to evaluate interaction between causes: A review of practices in cardiovascular epidemiology
8. Concepts of interaction
9. Interaction between Ace-Is and aspirin
10. Interaction between aspirin and ACE inhibitors in patients with heart failure
11. Does aspirin attenuate the beneficial effects of angiotensin-converting enzyme inhibition in heart failure?
12. The estimation of synergy or antagonism
13. Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis
14. ISIS-4 Fourth International Study of Infarct Survival Collaborative Group - ISIS-4: A randomised factorial trial assessing early oral captopril mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction
15. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: Results of the cooperative new scandinavian enalapril survival study II (CONSENSUS II)
16. GISSI-3: Effects of lisinopril and transdermal glycerine trinitrate singly and together on six week mortality and ventricular function after myocardial infarction
17. Oral captopril versus placebo among 13634 patients with suspected acute myocardial infarction: Interim report from the Chinese Cardiac Study (CCS-1)
18. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction
19. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the survival and ventricular enlargement trial (SAVE)
20. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction
21. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
22. Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: A cohort study of 11,575 patients with coronary artery disease
23. Clinical effect of angiotensin converting enzyme inhibitors treatment for acute myocardial infarction are similar in the presence and absence of aspirin
24. Interaction between enalapril and aspirin on mortality after acute myocardial infarction: Sub group analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)
25. Long term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients
26. What is the optimal medical management of ischaemic heart failure?